|
|
|
|
|
|
|
Thank you to Providence Saint Joseph Foundation for providing funding for this site.
For more information about funding opportunities please contact the Foundation at
818-847-4673.
To earn CME credits, please read our
FAQ's.
I have read the FAQ's and need to
Register.
I'm registered and need to LOGIN.
Please note: CME credit for videos expires one year after posting date.
As of July 1st, 2009, each activity is designated for a maximum of .75
AMA PRA Category 1 Credit(s)™.
|
|
Click the
button to view the videos in full screen
Current Strategies in the Diagnosis and Treatment of Neuroendocrine Tumors
LARRY KVOLS, M.D.
CHIEF, NEUROENDOCRINE TUMOR SECTION,
GASTROINTESTINAL ONCOLOGY PROGRAM, MOFFITT CANCER CENTER, TAMPA, FL
SUPPORT: We are grateful for the educational grant provided by Novartis in support of today’s activity.
MODERATOR: Lauren Vanderspek, M.D.; Department of Radiation Oncology, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following
Dr. Kvols discloses he is on the Speakers Bureau and is a consultant for Novartis, and is a consultant for Delcath and Pfizer. It is our policy to review presentations ahead of time to resolve any potential conflicts of interest.
OBJECTIVES
At the end of the presentation, attendees will be able to: - determine the incidence of euroendocrine tumors and classification of tumors.
- determine who is at risk and the role of genetic syndromes.
- recognize symptoms of neuroendocrine tumors and conduct an appropriate diagnostic workup.
- describe current strategies for treatment of neuroendocrine tumors, including surgical, medical and radiation strategies, and appropriate follow-up strategies.
- identify cultural/linguistic factors that impact the epidemiology, incidence, diagnosis, treatment, clinical course, and/or long-term outcomes of neuroendocrine tumors.
|
|
3/4/2010
|
|
Larry
Kvols,
MD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
|
|
Electroacupunture for Stroke Paresis: How does it work?
|
|
JEUNG CHOI, M.D.
DEPARTMENT OF MEDICINE, PSJMC
MODERATOR: James McGroarty, M.D.; Department of Surgery, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following:
Dr. Choi states he is president of Acu Med, Inc. His presentation was reviewed ahead of time and any conflicts of interest were resolved.
OBJECTIVES
At the end of the presentation, attendees will be able to: -
define electroacupuncture, its underlying philosophy, and mechanism of action.
- determine the safety and efficacy of electroacupuncture for post stroke patients.
- determine ethnic, generational and gender trends in the use of acupuncture in the United States.
|
|
|
|
|
|
|
|
|
|
|
|
|